Preventing recurrence of postpartum depression by regulating sleep

Verinder Sharma,Katherine M. Sharkey,Laura Palagini,Dwight Mazmanian,Michael Thomson
DOI: https://doi.org/10.1080/14737175.2023.2237194
IF: 4.287
2023-07-20
Expert Review of Neurotherapeutics
Abstract:Women are at a high risk of recurrence of depression in the postpartum period. Given the circumscribed duration of the risk period and knowledge of its triggers, postpartum depression should be easily preventable. However, prophylactic drug studies have reported contradictory findings partly due to the heterogeneity of the disorder. Currently, there are no studies on the efficacy of psychotherapy in the prevention of postpartum depression in women with major depressive or bipolar disorder. This review evaluates the results of controlled medication and psychotherapeutic studies in the prevention of depression in women with major depressive disorder or bipolar disorder; it further suggests that the management of sleep loss/insomnia may be an effective strategy in the prevention of postpartum depression. A thorough understanding of the clinical course of the antecedent mood disorder and historical treatment response is necessary before the implementation of strategies for the prevention of postpartum depression. Targeting disturbed and/or insufficient sleep – a common and early transdiagnostic symptom of peripartum psychiatric disorders – may be a more effective intervention for the prevention of postpartum depression and psychiatric comorbidities in some individuals than the traditional approach of antidepressant use.
pharmacology & pharmacy,clinical neurology
What problem does this paper attempt to address?